{"id": "article-26370_0", "title": "Osteitis Fibrosa Cystica -- Continuing Education Activity", "content": "Osteitis fibrosa cystica, often referred to as OFC, is a rare but clinically significant bone disorder characterized by profound skeletal changes resulting from excessive parathyroid hormone (PTH) activity. This condition is primarily associated with hyperparathyroidism, particularly in its severe and uncontrolled form, and is most commonly seen in patients with chronic kidney disease.\u00a0As PTH plays a pivotal role in regulating calcium levels in the body, its dysregulation can lead to a cascade of skeletal and systemic complications. OFC is characterized by the resorption of bone tissue, leading to the formation of cyst-like cavities within the bones and an increased risk of fractures, deformities, and metabolic abnormalities.\u00a0The incidence of this disorder has decreased significantly following earlier detection of hyperparathyroidism through routine screening of serum calcium in frequently asymptomatic patients.\u00a0Understanding the pathophysiology, clinical manifestations, diagnostic criteria, and management strategies for\u00a0OFC is essential for healthcare professionals in various specialties, as it plays a pivotal role in the comprehensive care of patients affected by this complex skeletal disorder. This activity reviews the evaluation and optimal management of\u00a0OFC and highlights the role of the\u00a0interprofessional team in detecting and treating this condition in affected individuals.", "contents": "Osteitis Fibrosa Cystica -- Continuing Education Activity. Osteitis fibrosa cystica, often referred to as OFC, is a rare but clinically significant bone disorder characterized by profound skeletal changes resulting from excessive parathyroid hormone (PTH) activity. This condition is primarily associated with hyperparathyroidism, particularly in its severe and uncontrolled form, and is most commonly seen in patients with chronic kidney disease.\u00a0As PTH plays a pivotal role in regulating calcium levels in the body, its dysregulation can lead to a cascade of skeletal and systemic complications. OFC is characterized by the resorption of bone tissue, leading to the formation of cyst-like cavities within the bones and an increased risk of fractures, deformities, and metabolic abnormalities.\u00a0The incidence of this disorder has decreased significantly following earlier detection of hyperparathyroidism through routine screening of serum calcium in frequently asymptomatic patients.\u00a0Understanding the pathophysiology, clinical manifestations, diagnostic criteria, and management strategies for\u00a0OFC is essential for healthcare professionals in various specialties, as it plays a pivotal role in the comprehensive care of patients affected by this complex skeletal disorder. This activity reviews the evaluation and optimal management of\u00a0OFC and highlights the role of the\u00a0interprofessional team in detecting and treating this condition in affected individuals."}
{"id": "article-26370_1", "title": "Osteitis Fibrosa Cystica -- Continuing Education Activity", "content": "Objectives: Identify risk factors for the development and progression of osteitis fibrosa cystica in at-risk patient populations. Select appropriate laboratory studies and, if indicated, imaging modalities\u00a0to evaluate\u00a0patients with osteitis fibrosa cystica. Implement evidence-based treatment protocols for osteitis fibrosa cystica, including vitamin D supplementation, parathyroidectomy, or pharmacological interventions as indicated. Collaborate with\u00a0an interprofessional team\u00a0to develop a comprehensive care plan for patients with osteitis fibrosa cystica, addressing primary and underlying conditions. Access free multiple choice questions on this topic.", "contents": "Osteitis Fibrosa Cystica -- Continuing Education Activity. Objectives: Identify risk factors for the development and progression of osteitis fibrosa cystica in at-risk patient populations. Select appropriate laboratory studies and, if indicated, imaging modalities\u00a0to evaluate\u00a0patients with osteitis fibrosa cystica. Implement evidence-based treatment protocols for osteitis fibrosa cystica, including vitamin D supplementation, parathyroidectomy, or pharmacological interventions as indicated. Collaborate with\u00a0an interprofessional team\u00a0to develop a comprehensive care plan for patients with osteitis fibrosa cystica, addressing primary and underlying conditions. Access free multiple choice questions on this topic."}
{"id": "article-26370_2", "title": "Osteitis Fibrosa Cystica -- Introduction", "content": "Osteitis fibrosa cystica (OFC), a disorder of skeletal bone, is a pathognomonic yet infrequent finding of late-stage hyperparathyroidism. OFC is also referred to by the eponym 'von Recklinghausen Disease of the Bone,' highlighting the description by Friedrich Daniel von Recklinghausen in 1891; however, it is noteworthy that the first description of this phenomenon was\u00a0posed 27 years earlier in 1864 by Gerhard Engel.\u00a0Moreover, it was not until 1904 that von Askanasy demonstrated the correlation between OFC and the parathyroid glands. [1]", "contents": "Osteitis Fibrosa Cystica -- Introduction. Osteitis fibrosa cystica (OFC), a disorder of skeletal bone, is a pathognomonic yet infrequent finding of late-stage hyperparathyroidism. OFC is also referred to by the eponym 'von Recklinghausen Disease of the Bone,' highlighting the description by Friedrich Daniel von Recklinghausen in 1891; however, it is noteworthy that the first description of this phenomenon was\u00a0posed 27 years earlier in 1864 by Gerhard Engel.\u00a0Moreover, it was not until 1904 that von Askanasy demonstrated the correlation between OFC and the parathyroid glands. [1]"}
{"id": "article-26370_3", "title": "Osteitis Fibrosa Cystica -- Introduction", "content": "OFC translates to 'cystic bone destruction' and occurs in the setting of chronic and sustained overactivity of the parathyroid glands with excessive release of parathyroid hormone (PTH) acting upon osseous tissues. [2] While once a common manifestation of hyperparathyroidism, OFC is now a rare occurrence in Western countries, especially in the United States, largely due to the introduction of auto analyzers in the 1970s-1980s, allowing earlier detection of even asymptomatic hyperparathyroidism and resultant prevention of late-stage\u00a0osseous manifestations. [3] [4]", "contents": "Osteitis Fibrosa Cystica -- Introduction. OFC translates to 'cystic bone destruction' and occurs in the setting of chronic and sustained overactivity of the parathyroid glands with excessive release of parathyroid hormone (PTH) acting upon osseous tissues. [2] While once a common manifestation of hyperparathyroidism, OFC is now a rare occurrence in Western countries, especially in the United States, largely due to the introduction of auto analyzers in the 1970s-1980s, allowing earlier detection of even asymptomatic hyperparathyroidism and resultant prevention of late-stage\u00a0osseous manifestations. [3] [4]"}
{"id": "article-26370_4", "title": "Osteitis Fibrosa Cystica -- Introduction", "content": "OFC may occur in any setting of sustained elevation of PTH, including primary, secondary, and tertiary hyperparathyroidism. Excessive osteoclast activation manifests as but is not limited to, bone swelling, pain, deformity, depleted bone mineral density, and fractures. Lesions may be either single or multiple and are\u00a0characterized histologically\u00a0as \"brown tumors\" due to repetitive microtrauma and microfractures, leading to\u00a0hemosiderin deposition; however, this is a misnomer, as they do not harbor neoplastic potential. [5] While\u00a0OFC may be progressive alongside continued activation of the parathyroid glands and stimulation of the osteoclasts, treatment of the underlying disorder of hyperparathyroidism, most often\u00a0with a parathyroidectomy, is curative with ultimate resolution of the disease. [6]", "contents": "Osteitis Fibrosa Cystica -- Introduction. OFC may occur in any setting of sustained elevation of PTH, including primary, secondary, and tertiary hyperparathyroidism. Excessive osteoclast activation manifests as but is not limited to, bone swelling, pain, deformity, depleted bone mineral density, and fractures. Lesions may be either single or multiple and are\u00a0characterized histologically\u00a0as \"brown tumors\" due to repetitive microtrauma and microfractures, leading to\u00a0hemosiderin deposition; however, this is a misnomer, as they do not harbor neoplastic potential. [5] While\u00a0OFC may be progressive alongside continued activation of the parathyroid glands and stimulation of the osteoclasts, treatment of the underlying disorder of hyperparathyroidism, most often\u00a0with a parathyroidectomy, is curative with ultimate resolution of the disease. [6]"}
{"id": "article-26370_5", "title": "Osteitis Fibrosa Cystica -- Etiology", "content": "OFC may occur in any setting of\u00a0PTH overproduction, including primary (both normocalcaemic and hypercalcemic), secondary,\u00a0and tertiary hyperparathyroidism. [7] [8] [9] [10] Notably,\u00a0OFC is a frequent manifestation of end-stage renal disease. [11] Regarding primary hyperparathyroidism, this is most commonly due to a sporadic adenoma in up to 85% of cases and less frequently associated with parathyroid carcinoma, however, both have been associated with OFC.\u00a0In the setting of carcinoma, one must distinguish\u00a0OFC from osseous metastases. [12] Additionally, genetic causes of primary hyperparathyroidism, including hyperparathyroidism jaw-tumor syndrome, familial isolated hyperparathyroidism, and multiple endocrine neoplasia, have all been associated with OFC. OFC has also been demonstrated in the case of pseudohypoparathyroidism, which occurs with elevated\u00a0PTH in the absence of hypercalcemia, mostly due to variable end-organ resistance. [13] As a final consideration,\u00a0OFC has been demonstrated to occur in cases of elevated PTH-related peptide (where the PTH level will be suppressed), such as ectopic production by adult T-cell leukemia. [14]", "contents": "Osteitis Fibrosa Cystica -- Etiology. OFC may occur in any setting of\u00a0PTH overproduction, including primary (both normocalcaemic and hypercalcemic), secondary,\u00a0and tertiary hyperparathyroidism. [7] [8] [9] [10] Notably,\u00a0OFC is a frequent manifestation of end-stage renal disease. [11] Regarding primary hyperparathyroidism, this is most commonly due to a sporadic adenoma in up to 85% of cases and less frequently associated with parathyroid carcinoma, however, both have been associated with OFC.\u00a0In the setting of carcinoma, one must distinguish\u00a0OFC from osseous metastases. [12] Additionally, genetic causes of primary hyperparathyroidism, including hyperparathyroidism jaw-tumor syndrome, familial isolated hyperparathyroidism, and multiple endocrine neoplasia, have all been associated with OFC. OFC has also been demonstrated in the case of pseudohypoparathyroidism, which occurs with elevated\u00a0PTH in the absence of hypercalcemia, mostly due to variable end-organ resistance. [13] As a final consideration,\u00a0OFC has been demonstrated to occur in cases of elevated PTH-related peptide (where the PTH level will be suppressed), such as ectopic production by adult T-cell leukemia. [14]"}
{"id": "article-26370_6", "title": "Osteitis Fibrosa Cystica -- Epidemiology", "content": "Following routine detection of asymptomatic hypercalcemia with a subsequent diagnosis of hyperparathyroidism through the addition of the auto analyzer in clinical practice, the prevalence of hyperparathyroidism has increased, however, concurrent \u2018severe\u2019 disease has decreased reciprocally. [2] While\u00a0OFC was once a common manifestation of hyperparathyroidism with a prevalence of approximately 69%, the prevalence in the United States has significantly decreased over the last 50 years to approximately 5% with primary hyperparathyroidism and 1.5% with secondary hyperparathyroidism. [4] [15] In contrast, developing nations continue to demonstrate an excessive prevalence of OFC and\u00a0other late sequelae of hyperparathyroidism due to the\u00a0unavailability of earlier detection. [16]", "contents": "Osteitis Fibrosa Cystica -- Epidemiology. Following routine detection of asymptomatic hypercalcemia with a subsequent diagnosis of hyperparathyroidism through the addition of the auto analyzer in clinical practice, the prevalence of hyperparathyroidism has increased, however, concurrent \u2018severe\u2019 disease has decreased reciprocally. [2] While\u00a0OFC was once a common manifestation of hyperparathyroidism with a prevalence of approximately 69%, the prevalence in the United States has significantly decreased over the last 50 years to approximately 5% with primary hyperparathyroidism and 1.5% with secondary hyperparathyroidism. [4] [15] In contrast, developing nations continue to demonstrate an excessive prevalence of OFC and\u00a0other late sequelae of hyperparathyroidism due to the\u00a0unavailability of earlier detection. [16]"}
{"id": "article-26370_7", "title": "Osteitis Fibrosa Cystica -- Epidemiology", "content": "Brown tumors, the distinctive histopathological finding of localized OFC, appear to be more common in persons older than 50 years, in addition to the female gender, for which it is hypothesized that there is an element of hormonal involvement for its development. [5] Alternative theories, as to why\u00a0the development of OFC, as well as the presence of parathyroid carcinoma, in which case the\u00a0OFC occurs in about 90% of patients compared to a mere 5% of patients with benign disease that, may be due to the higher serum\u00a0PTH associated with carcinomas. [17] [18]", "contents": "Osteitis Fibrosa Cystica -- Epidemiology. Brown tumors, the distinctive histopathological finding of localized OFC, appear to be more common in persons older than 50 years, in addition to the female gender, for which it is hypothesized that there is an element of hormonal involvement for its development. [5] Alternative theories, as to why\u00a0the development of OFC, as well as the presence of parathyroid carcinoma, in which case the\u00a0OFC occurs in about 90% of patients compared to a mere 5% of patients with benign disease that, may be due to the higher serum\u00a0PTH associated with carcinomas. [17] [18]"}
{"id": "article-26370_8", "title": "Osteitis Fibrosa Cystica -- Pathophysiology", "content": "Sustained overproduction of\u00a0PTH leads to the sequelae of hyperparathyroidism, including OFC. The most commonly involved body areas include the pelvic girdle, mandible (but not maxilla, which is an uncommon location), clavicle, ribs, and ends of long bones; however, with the progression of the disease, no bone is spared from possible involvement. [19]", "contents": "Osteitis Fibrosa Cystica -- Pathophysiology. Sustained overproduction of\u00a0PTH leads to the sequelae of hyperparathyroidism, including OFC. The most commonly involved body areas include the pelvic girdle, mandible (but not maxilla, which is an uncommon location), clavicle, ribs, and ends of long bones; however, with the progression of the disease, no bone is spared from possible involvement. [19]"}
{"id": "article-26370_9", "title": "Osteitis Fibrosa Cystica -- Pathophysiology", "content": "Excessive\u00a0PTH binds to osteoblasts, which leads to the expression of receptor activator of nuclear factor kappa-\u03b2 ligand (RANKL), which itself attaches to receptor activator of nuclear factor kappa-\u03b2 (RANK) on osteoclast precursors, allowing differentiation into osteoclasts and inhibition of osteoprotegerin expression. The osteoprotegerin functions to bind to RANKL and prevent interaction with RANK. [20] [21] With the activation of osteoclasts, bone resorption commences through cortical destruction and fibrous cyst formation. Brown tumors are formed with the replacement of the marrow with vascularized fibrous tissue and repetitive microfractures and microhemorrhages, producing the clinical manifestations of pain, weakening, swelling, deformities, and risk for fracture. [22] [23]", "contents": "Osteitis Fibrosa Cystica -- Pathophysiology. Excessive\u00a0PTH binds to osteoblasts, which leads to the expression of receptor activator of nuclear factor kappa-\u03b2 ligand (RANKL), which itself attaches to receptor activator of nuclear factor kappa-\u03b2 (RANK) on osteoclast precursors, allowing differentiation into osteoclasts and inhibition of osteoprotegerin expression. The osteoprotegerin functions to bind to RANKL and prevent interaction with RANK. [20] [21] With the activation of osteoclasts, bone resorption commences through cortical destruction and fibrous cyst formation. Brown tumors are formed with the replacement of the marrow with vascularized fibrous tissue and repetitive microfractures and microhemorrhages, producing the clinical manifestations of pain, weakening, swelling, deformities, and risk for fracture. [22] [23]"}
{"id": "article-26370_10", "title": "Osteitis Fibrosa Cystica -- Histopathology", "content": "Brown tumors, also known as osteoclastomas, are the classic histological manifestation of OFC\u00a0and represent localized disease. [24] Microscopically,\u00a0OFC is notable foh osteoclast and osteoblast activity within the osseous tissue alongside hemosiderin-laden macrophages and cyst formation from rapid bone loss and subsequent hemorrhage, granulation, and fibrous tissue replenishment within the marrow. [25]", "contents": "Osteitis Fibrosa Cystica -- Histopathology. Brown tumors, also known as osteoclastomas, are the classic histological manifestation of OFC\u00a0and represent localized disease. [24] Microscopically,\u00a0OFC is notable foh osteoclast and osteoblast activity within the osseous tissue alongside hemosiderin-laden macrophages and cyst formation from rapid bone loss and subsequent hemorrhage, granulation, and fibrous tissue replenishment within the marrow. [25]"}
{"id": "article-26370_11", "title": "Osteitis Fibrosa Cystica -- History and Physical", "content": "History taking should begin with assessing the disease duration, previous treatments received, and previous records to review the severity of the hyperparathyroidism. It is important to note that patients with\u00a0OFC have likely had a long duration of hyperparathyroidism or have severe disease, and in addition to musculoskeletal manifestations, may demonstrate other end-organ complications, including renal (kidney stones, failure, polyuria), abdominal (pancreatitis, ulceration, nausea, vomiting, constipation), and psychiatric disturbances (fatigue, lethargy, disturbances with memory, depression).", "contents": "Osteitis Fibrosa Cystica -- History and Physical. History taking should begin with assessing the disease duration, previous treatments received, and previous records to review the severity of the hyperparathyroidism. It is important to note that patients with\u00a0OFC have likely had a long duration of hyperparathyroidism or have severe disease, and in addition to musculoskeletal manifestations, may demonstrate other end-organ complications, including renal (kidney stones, failure, polyuria), abdominal (pancreatitis, ulceration, nausea, vomiting, constipation), and psychiatric disturbances (fatigue, lethargy, disturbances with memory, depression)."}
{"id": "article-26370_12", "title": "Osteitis Fibrosa Cystica -- History and Physical", "content": "Regarding musculoskeletal manifestations, it is essential to assess for a history of pathological fractures, review previous imaging of the skeleton (looking\u00a0for osteopenia or osteoporosis), ask the patient about pain, and investigate for deformities of the bones, including bowing of the long bones. Moreover, depressed reflexes can be associated\u00a0with hypercalcemia and can be reproduced upon physical examination. While any bone can be affected in OFC, most commonly, it is the mandible, clavicle, pelvic girdle, and ribs, which should prompt consideration of the presence of OFC. [19] Physical examination should also include a head and neck exam, assessing for a palpable mass over the anterior neck consistent with a parathyroid adenoma or carcinoma.", "contents": "Osteitis Fibrosa Cystica -- History and Physical. Regarding musculoskeletal manifestations, it is essential to assess for a history of pathological fractures, review previous imaging of the skeleton (looking\u00a0for osteopenia or osteoporosis), ask the patient about pain, and investigate for deformities of the bones, including bowing of the long bones. Moreover, depressed reflexes can be associated\u00a0with hypercalcemia and can be reproduced upon physical examination. While any bone can be affected in OFC, most commonly, it is the mandible, clavicle, pelvic girdle, and ribs, which should prompt consideration of the presence of OFC. [19] Physical examination should also include a head and neck exam, assessing for a palpable mass over the anterior neck consistent with a parathyroid adenoma or carcinoma."}
{"id": "article-26370_13", "title": "Osteitis Fibrosa Cystica -- Evaluation", "content": "Due to the infrequent occurrence of OFC, routine radiological screening in the absence of clinical suspicion (such as\u00a0in asymptomatic patients) is not warranted. [1] [26] As discussed in the previous section, a concerning history and physical examination are justifiable for further radiological assessment. Classical radiological descriptions of\u00a0OFC include a \"salt-and-pepper\" skull, subperiosteal bone resorption of the second and third fingers at the proximal and middle phalanges, involvement of the distal clavicle, as well as widespread brown tumors and bone cysts. [27] Generalized decreased mineral density of the bone (osteopenia) may be noted,\u00a0with cortical bone being involved more commonly than cancellous bone. [6] A bone biopsy can be considered and may differentiate\u00a0OFC from a bone tumor. [28] A caveat, however, is the risk of seeding of the cancerous cells in the setting of malignancy.", "contents": "Osteitis Fibrosa Cystica -- Evaluation. Due to the infrequent occurrence of OFC, routine radiological screening in the absence of clinical suspicion (such as\u00a0in asymptomatic patients) is not warranted. [1] [26] As discussed in the previous section, a concerning history and physical examination are justifiable for further radiological assessment. Classical radiological descriptions of\u00a0OFC include a \"salt-and-pepper\" skull, subperiosteal bone resorption of the second and third fingers at the proximal and middle phalanges, involvement of the distal clavicle, as well as widespread brown tumors and bone cysts. [27] Generalized decreased mineral density of the bone (osteopenia) may be noted,\u00a0with cortical bone being involved more commonly than cancellous bone. [6] A bone biopsy can be considered and may differentiate\u00a0OFC from a bone tumor. [28] A caveat, however, is the risk of seeding of the cancerous cells in the setting of malignancy."}
{"id": "article-26370_14", "title": "Osteitis Fibrosa Cystica -- Evaluation", "content": "Laboratory findings of hyperparathyroidism include hypercalcemia (albeit occasionally may demonstrate normocalcemia), elevated, or inappropriately normal, PTH, hypophosphatemia, and elevated alkaline phosphatase (the latter correlating with the degree of overt OFC). [8] In the setting of suppressed PTH, this should lead to the consideration of hypercalcemia of malignancy, for which the underlying cancerous tissue must be identified, in addition to consultation with an oncologist. The presence of hyperparathyroidism in a young patient or a patient with a strong family history should prompt consideration of a genetic cause, with a referral to a geneticist.", "contents": "Osteitis Fibrosa Cystica -- Evaluation. Laboratory findings of hyperparathyroidism include hypercalcemia (albeit occasionally may demonstrate normocalcemia), elevated, or inappropriately normal, PTH, hypophosphatemia, and elevated alkaline phosphatase (the latter correlating with the degree of overt OFC). [8] In the setting of suppressed PTH, this should lead to the consideration of hypercalcemia of malignancy, for which the underlying cancerous tissue must be identified, in addition to consultation with an oncologist. The presence of hyperparathyroidism in a young patient or a patient with a strong family history should prompt consideration of a genetic cause, with a referral to a geneticist."}
{"id": "article-26370_15", "title": "Osteitis Fibrosa Cystica -- Evaluation", "content": "In the setting of OFC, parathyroidectomy is the treatment of choice,\u00a0leading to the resolution of disease; however, this requires surgical planning prior to the procedure. As a result, patients may undergo an ultrasound scan of the neck to identify the parathyroid glands, in addition to a sestamibi scan that would assist in confirming the location and potentially identifying any ectopic glandular tissue.", "contents": "Osteitis Fibrosa Cystica -- Evaluation. In the setting of OFC, parathyroidectomy is the treatment of choice,\u00a0leading to the resolution of disease; however, this requires surgical planning prior to the procedure. As a result, patients may undergo an ultrasound scan of the neck to identify the parathyroid glands, in addition to a sestamibi scan that would assist in confirming the location and potentially identifying any ectopic glandular tissue."}
{"id": "article-26370_16", "title": "Osteitis Fibrosa Cystica -- Treatment / Management", "content": "Treatment of\u00a0OFC involves targeting the underlying cause of hyperparathyroidism. In the setting of primary hyperparathyroidism, it will require parathyroidectomy, for which resolution of the brown tumors is expected, rendering surgery redundant.\u00a0Local surgical procedures (such as incisions) may be performed at sites of\u00a0OFC in the setting of\u00a0functional problems, most notably persistent deformity, pathological fractures, and discomfort. Infrequent case reports have noted the usage of corticosteroids to decrease the tumor size should it persist post-parathyroidectomy. [25] Treatment of\u00a0OFC has also been shown with refrigerated transplantation of osseous tissue, demonstrating resolution of the lesions on follow-up after curettage and packing of the cavity with refrigerated bone chips. [29]", "contents": "Osteitis Fibrosa Cystica -- Treatment / Management. Treatment of\u00a0OFC involves targeting the underlying cause of hyperparathyroidism. In the setting of primary hyperparathyroidism, it will require parathyroidectomy, for which resolution of the brown tumors is expected, rendering surgery redundant.\u00a0Local surgical procedures (such as incisions) may be performed at sites of\u00a0OFC in the setting of\u00a0functional problems, most notably persistent deformity, pathological fractures, and discomfort. Infrequent case reports have noted the usage of corticosteroids to decrease the tumor size should it persist post-parathyroidectomy. [25] Treatment of\u00a0OFC has also been shown with refrigerated transplantation of osseous tissue, demonstrating resolution of the lesions on follow-up after curettage and packing of the cavity with refrigerated bone chips. [29]"}
{"id": "article-26370_17", "title": "Osteitis Fibrosa Cystica -- Treatment / Management", "content": "It is also imperative to manage the underlying renal disease, especially in the setting of secondary hyperparathyroidism, and to treat co-existent vitamin D deficiency, which can lead to more severe musculoskeletal complications. It has also been demonstrated that oral vitamin D can lead to the regression of brown tumors and symptoms of OFC. [30]", "contents": "Osteitis Fibrosa Cystica -- Treatment / Management. It is also imperative to manage the underlying renal disease, especially in the setting of secondary hyperparathyroidism, and to treat co-existent vitamin D deficiency, which can lead to more severe musculoskeletal complications. It has also been demonstrated that oral vitamin D can lead to the regression of brown tumors and symptoms of OFC. [30]"}
{"id": "article-26370_18", "title": "Osteitis Fibrosa Cystica -- Differential Diagnosis", "content": "As\u00a0OFC is rather uncommon, it is infrequently considered in the differential diagnosis, however, it is nonetheless an important differential diagnosis as its recognition would help avoid unnecessary invasive testing and procedures. [27] The presence of hypercalcemia and lytic bone lesions leads to a consideration of hypercalcemia of malignancy versus\u00a0OFC from hyperparathyroidism itself. This is best differentiated by the measurement of PTH, which is depressed in hypercalcemia of malignancy but elevated (or inappropriately normal) in OFC.\u00a0OFC can occasionally mimic metastatic parathyroid carcinoma, albeit this is very uncommon. [9]", "contents": "Osteitis Fibrosa Cystica -- Differential Diagnosis. As\u00a0OFC is rather uncommon, it is infrequently considered in the differential diagnosis, however, it is nonetheless an important differential diagnosis as its recognition would help avoid unnecessary invasive testing and procedures. [27] The presence of hypercalcemia and lytic bone lesions leads to a consideration of hypercalcemia of malignancy versus\u00a0OFC from hyperparathyroidism itself. This is best differentiated by the measurement of PTH, which is depressed in hypercalcemia of malignancy but elevated (or inappropriately normal) in OFC.\u00a0OFC can occasionally mimic metastatic parathyroid carcinoma, albeit this is very uncommon. [9]"}
{"id": "article-26370_19", "title": "Osteitis Fibrosa Cystica -- Differential Diagnosis", "content": "Further differential diagnoses include giant bone marrow tumors, solid aneurysmal bone cysts, and a giant cell reparative granuloma. [1] [27] The distinction between the aforementioned conditions may pose challenges. [28] While bone scintigraphy can assess areas of increased uptake associated with hyperparathyroidism, this may be falsely positive for malignancy, osteomalacia, and infection.\u00a0Similarly, a positron emission tomography scan cannot distinguish between benign and malignant osseous neoplasms.\u00a0Furthermore, the histological assessment may demonstrate overlap between these conditions, leading to difficulty in differentiation and accurate diagnosis. [1]", "contents": "Osteitis Fibrosa Cystica -- Differential Diagnosis. Further differential diagnoses include giant bone marrow tumors, solid aneurysmal bone cysts, and a giant cell reparative granuloma. [1] [27] The distinction between the aforementioned conditions may pose challenges. [28] While bone scintigraphy can assess areas of increased uptake associated with hyperparathyroidism, this may be falsely positive for malignancy, osteomalacia, and infection.\u00a0Similarly, a positron emission tomography scan cannot distinguish between benign and malignant osseous neoplasms.\u00a0Furthermore, the histological assessment may demonstrate overlap between these conditions, leading to difficulty in differentiation and accurate diagnosis. [1]"}
{"id": "article-26370_20", "title": "Osteitis Fibrosa Cystica -- Prognosis", "content": "Untreated\u00a0OFC parallels the severity of hyperparathyroidism, and treatment requires resolution of the underlying hyperparathyroidism. Although\u00a0OFC is a dire condition associated with suffering, the prognosis is\u00a0favorable if the underlying disease driving the hyperparathyroidism can be controlled. OFC typically resolves following parathyroidectomy in the setting of primary hyperparathyroidism, rendering surgical management of the brown tumors unnecessary. It has been demonstrated that bone remineralization of the skeleton occurs, with the recovery of osteopenia and healing of the brown tumors upon radiological and histological assessment, in addition to clinical improvement expressed by both the patient and objective examination. [3]", "contents": "Osteitis Fibrosa Cystica -- Prognosis. Untreated\u00a0OFC parallels the severity of hyperparathyroidism, and treatment requires resolution of the underlying hyperparathyroidism. Although\u00a0OFC is a dire condition associated with suffering, the prognosis is\u00a0favorable if the underlying disease driving the hyperparathyroidism can be controlled. OFC typically resolves following parathyroidectomy in the setting of primary hyperparathyroidism, rendering surgical management of the brown tumors unnecessary. It has been demonstrated that bone remineralization of the skeleton occurs, with the recovery of osteopenia and healing of the brown tumors upon radiological and histological assessment, in addition to clinical improvement expressed by both the patient and objective examination. [3]"}
{"id": "article-26370_21", "title": "Osteitis Fibrosa Cystica -- Complications", "content": "OFC, if left untreated, may lead to perpetual pain, musculoskeletal weakness, deformities, erosions, bowing of the bones, cyst development, and fractures. Furthermore, with OFC, patients are likely to have other complications of hyperparathyroidism present, including nephrolithiasis, renal failure, fatigue, abdominal pain, psychiatric disturbances, and polyuria. [27]", "contents": "Osteitis Fibrosa Cystica -- Complications. OFC, if left untreated, may lead to perpetual pain, musculoskeletal weakness, deformities, erosions, bowing of the bones, cyst development, and fractures. Furthermore, with OFC, patients are likely to have other complications of hyperparathyroidism present, including nephrolithiasis, renal failure, fatigue, abdominal pain, psychiatric disturbances, and polyuria. [27]"}
{"id": "article-26370_22", "title": "Osteitis Fibrosa Cystica -- Deterrence and Patient Education", "content": "In the United States,\u00a0OFC is an infrequent manifestation (<5%) of hyperparathyroidism, occurring in those with longer duration and more severe disease. Hypercalcemia is routinely detected most commonly in asymptomatic patients during routine medical check-ups prior to end-organ manifestations; however, in developing countries where routine check-ups are not available,\u00a0OFC and other manifestations of hyperparathyroidism are more frequently seen. It is essential to consider this uncommon complication to recognize the symptoms of bone pain, swelling, deformity, and weakness in cases of severe and untreated disease.", "contents": "Osteitis Fibrosa Cystica -- Deterrence and Patient Education. In the United States,\u00a0OFC is an infrequent manifestation (<5%) of hyperparathyroidism, occurring in those with longer duration and more severe disease. Hypercalcemia is routinely detected most commonly in asymptomatic patients during routine medical check-ups prior to end-organ manifestations; however, in developing countries where routine check-ups are not available,\u00a0OFC and other manifestations of hyperparathyroidism are more frequently seen. It is essential to consider this uncommon complication to recognize the symptoms of bone pain, swelling, deformity, and weakness in cases of severe and untreated disease."}
{"id": "article-26370_23", "title": "Osteitis Fibrosa Cystica -- Enhancing Healthcare Team Outcomes", "content": "Early diagnosis of hyperparathyroidism is vital to limit end-organ damage and prevent complications such as OFC. Due to the infrequent nature of this phenomenon, however, routine radiological screening is not indicated in the absence of suspicion for OFC. Patient-centered education is a valuable tool for which the\u00a0demonstration of symptoms concerning\u00a0OFC (such as bone pain, weakness, deformities, and swelling) should prompt urgent evaluation to prevent untoward bone complications. Apart from the endocrinology department, other healthcare professionals are likely to be in contact with such patients,\u00a0emphasizing the importance of early recognition of signs and symptoms of\u00a0OFC.", "contents": "Osteitis Fibrosa Cystica -- Enhancing Healthcare Team Outcomes. Early diagnosis of hyperparathyroidism is vital to limit end-organ damage and prevent complications such as OFC. Due to the infrequent nature of this phenomenon, however, routine radiological screening is not indicated in the absence of suspicion for OFC. Patient-centered education is a valuable tool for which the\u00a0demonstration of symptoms concerning\u00a0OFC (such as bone pain, weakness, deformities, and swelling) should prompt urgent evaluation to prevent untoward bone complications. Apart from the endocrinology department, other healthcare professionals are likely to be in contact with such patients,\u00a0emphasizing the importance of early recognition of signs and symptoms of\u00a0OFC."}
{"id": "article-26370_24", "title": "Osteitis Fibrosa Cystica -- Enhancing Healthcare Team Outcomes", "content": "Enhancing patient-centered care and improving outcomes for individuals with OFC requires a collaborative approach involving physicians, advanced care practitioners, nurses, pharmacists, and other healthcare professionals.\u00a0Clinicians\u00a0must possess a deep understanding of OFC, its pathophysiology, diagnostic methods, and treatment options. This includes proficiency in interpreting bone scans, laboratory results, and monitoring bone health. Collaborative teams should develop individualized care plans based on patient-specific factors, including the severity of OFC, comorbid conditions, and patient preferences. Advocacy for patients' needs, including referrals to specialists, physical therapy, or counseling services, is a shared responsibility among the interprofessional team. By fostering strong\u00a0multidisciplinary collaboration, healthcare professionals can provide patient-centered care that addresses the unique challenges OFC poses. This approach enhances patient safety, improves outcomes, and optimizes the overall care experience for individuals with this rare bone disorder.", "contents": "Osteitis Fibrosa Cystica -- Enhancing Healthcare Team Outcomes. Enhancing patient-centered care and improving outcomes for individuals with OFC requires a collaborative approach involving physicians, advanced care practitioners, nurses, pharmacists, and other healthcare professionals.\u00a0Clinicians\u00a0must possess a deep understanding of OFC, its pathophysiology, diagnostic methods, and treatment options. This includes proficiency in interpreting bone scans, laboratory results, and monitoring bone health. Collaborative teams should develop individualized care plans based on patient-specific factors, including the severity of OFC, comorbid conditions, and patient preferences. Advocacy for patients' needs, including referrals to specialists, physical therapy, or counseling services, is a shared responsibility among the interprofessional team. By fostering strong\u00a0multidisciplinary collaboration, healthcare professionals can provide patient-centered care that addresses the unique challenges OFC poses. This approach enhances patient safety, improves outcomes, and optimizes the overall care experience for individuals with this rare bone disorder."}
{"id": "article-26370_25", "title": "Osteitis Fibrosa Cystica -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Osteitis Fibrosa Cystica -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}